1. |
Woolsey ID, Miller AL. Echinococcus granulosus sensu lato and Echinococcus multilocularis: a review. Res Vet Sci, 2021, 135: 517-522.
|
2. |
Kristianova H, Kolarova L, Krska Z, et al. Surgical treatment of alveolar echinococcosis: a single centre experience and systematic review of the literature. Rozhl Chir, 2019, 98(4): 167-173.
|
3. |
Guan D, Li C, Lv X, et al. Pseudolaric acid B inhibits PAX2 expression through Wnt signaling and induces BAX expression, therefore promoting apoptosis in HeLa cervical cancer cells. J Gynecol Oncol, 2019, 30(5): e77. doi: 10.3802/jgo.2019.30.e77.
|
4. |
Liu ML, Sun D, Li T, et al. A systematic review of the immune-regulating and anticancer activities of pseudolaric acid B. Front Pharmacol, 2017, 8: 394. doi: 10.3389/fphar.2017.00394.
|
5. |
Choi SJ, Ahn CH, Yang IH, et al. Pseudolaric acid B induces growth inhibition and caspase-dependent apoptosis on head and neck cancer cell lines through death receptor 5. Molecules, 2019, 24(20): 3715. doi: 10.3390/molecules24203715.
|
6. |
Gao H, Huo L, Mo X, et al. Suppressive effect of pseudolaric acid B on Echinococcus multilocularis involving regulation of TGF-β1 signaling in vitro and in vivo. Front Microbiol, 2022, 13: 1008274. doi: 10.3389/fmicb.2022.1008274.
|
7. |
Autier B, Manuel C, Lundstroem-Stadelmann B, et al. Endogenous IL-33 accelerates metacestode growth during late-stage alveolar Echinococcosis. Microbiol Spectr, 2023, 11(2): e0423922. doi: 10.1128/spectrum.04239-22.
|
8. |
陈青, 刘川川, 李彩霞, 等. 棘球蚴病中药治疗研究进展. 中国血吸虫病防治杂志, 2023, 35(4): 398-406, 412.
|
9. |
Li MH, Miao ZH, Tan WF, et al. Pseudolaric acid B inhibits angiogenesis and reduces hypoxia-inducible factor 1alpha by promoting proteasome-mediated degradation. Clin Cancer Res, 2004, 10(24): 8266-8274.
|
10. |
Wang D, Tian Y, Feng W, et al. Pseudolaric acid B induces endometrial cancer Ishikawa cell apoptosis and inhibits metastasis through AKT-GSK-3β and ERK1/2 signaling pathways. Anticancer Drugs, 2017, 28(6): 603-612.
|
11. |
Gong XF, Wang MW, Tashiro S, et al. Pseudolaric acid B induces apoptosis through p53 and Bax/Bcl-2 pathways in human melanoma A375-S2 cells. Arch Pharm Res, 2005, 28(1): 68-72.
|
12. |
Stadelmann B, Spiliotis M, Müller J, et al. Echinococcus multilocularis phosphoglucose isomerase (EmPGI): a glycolytic enzyme involved in metacestode growth and parasite-host cell interactions. Int J Parasitol, 2010, 40(13): 1563-1574.
|
13. |
Stadelmann B, Scholl S, Müller J, et al. Application of an in vitro drug screening assay based on the release of phosphoglucose isomerase to determine the structure-activity relationship of thiazolides against Echinococcus multilocularis metacestodes. J Antimicrob Chemother, 2010, 65(3): 512-519.
|
14. |
Gottstein B, Soboslay P, Ortona E, et al. Immunology of alveolar and cystic Echinococcosis (AE and CE). Adv Parasitol, 2017, 96:1-54.
|
15. |
Brehm K, Koziol U. On the importance of targeting parasite stem cells in anti-echinococcosis drug development. Parasite, 2014, 21: 72. doi: 10.1051/parasite/2014070.
|
16. |
Chen SQ, Wang J, Zhao C, et al. Synthesis and biological evaluation of pseudolaric acid B derivatives as potential immunosuppressive agents. J Asian Nat Prod Res, 2015, 17(8): 828-837.
|
17. |
Spitz AZ, Gavathiotis E. Physiological and pharmacological modulation of BAX. Trends Pharmacol Sci, 2022, 43(3): 206-220.
|
18. |
Liu Z, Wang N, Meng Z, et al. Pseudolaric acid B triggers cell apoptosis by activating AMPK/JNK/DRP1/mitochondrial fission pathway in hepatocellular carcinoma. Toxicology, 2023, 493: 153556. doi: 10.1016/j.tox.2023.153556.
|
19. |
Liu C, Cao J, Zhang H, et al. Extracellular vesicles secreted by Echinococcus multilocularis: important players in angiogenesis promotion. Microbes Infect, 2023, 25(7): 105147. doi: 10.1016/j.micinf.2023.105147.
|
20. |
姜慧娇, 桂显伟, 郭黎姣, 等. VEGFA/VEGFR2在小鼠肝多房棘球蚴组织血管生成中的表达及作用. 中国寄生虫学与寄生虫病杂志, 2020, 38(6): 673-681.
|
21. |
Yin Z, Cai H, Wang Z, et al. Pseudolaric acid B inhibits proliferation, invasion, and angiogenesis in esophageal squamous cell carcinoma through regulating CD147. Drug Des Devel Ther, 2020, 14: 4561-4573.
|
22. |
Zhong N, Zhuang W, Huang Q, et al. Apatinib inhibits the growth of small cell lung cancer via a mechanism mediated by VEGF, PI3K/Akt and Ki-67/CD31. J Cell Mol Med, 2021, 25(21): 10039-10048.
|
23. |
宋佳易, 刘春英. 土荆皮乙酸通过PI3K/AKT通路抑制肺腺癌细胞A549上皮-间质转化. 中国免疫学杂志, 2022, 38(2): 171-174.
|
24. |
Wang D, Xin Y, Tian Y, et al. Pseudolaric acid B inhibits gastric cancer cell metastasis in vitro and in haematogenous dissemination model through PI3K/AKT, ERK1/2 and mitochondria-mediated apoptosis pathways. Exp Cell Res, 2017, 352(1): 34-44.
|
25. |
Song J, Guan Z, Song C, et al. Apatinib suppresses the migration, invasion and angiogenesis of hepatocellular carcinoma cells by blocking VEGF and PI3K/AKT signaling pathways. Mol Med Rep, 2021, 23(6): 429. doi: 10.3892/mmr.2021.12068.
|
26. |
Duan MX, Zhou H, Wu QQ, et al. Andrographolide protects against HG-induced inflammation, apoptosis, migration, and impairment of angiogenesis via PI3K/AKT-eNOS signalling in HUVECs. Mediators Inflamm, 2019, 2019: 6168340.
|
27. |
马慧, 种世桂, 陈根, 等. 多房棘球蚴病相关细胞信号通路的研究进展. 中国寄生虫学与寄生虫病杂志, 2023, 41(2): 223-227, 232.
|
28. |
Sarkar T, Nguyen TL, Su ZW, et al. Interaction of pseudolaric acid B with the colchicine site of tubulin. Biochem Pharmacol, 2012, 84(4): 444-450.
|